Uncategorized
Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects
Findings of the IMPORT LOW trial, led by researchers at the University of Cambridge and The Institute of Cancer Research,
julio 15, 2025
No hay comentarios